Why do hb electrophoresis

Overview

Hemoglobin electrophoresis is a laboratory technique used to separate and identify different types of hemoglobin in blood samples. Developed in the mid-20th century, this diagnostic method revolutionized the detection of hemoglobinopathies - inherited disorders affecting hemoglobin structure or production. The technique originated from early electrophoresis methods pioneered by Arne Tiselius in the 1930s, who won the Nobel Prize in Chemistry in 1948 for his work on electrophoresis and adsorption analysis. Clinical applications expanded significantly in the 1960s when researchers developed improved supporting media including cellulose acetate and citrate agar gels. Today, hemoglobin electrophoresis remains essential for diagnosing conditions like sickle cell disease (first described by James Herrick in 1910) and various thalassemia syndromes. The test is particularly crucial in neonatal screening programs, with all 50 U.S. states requiring newborn screening for sickle cell disease since 2006.

How It Works

Hemoglobin electrophoresis operates on the principle that different hemoglobin variants migrate at different rates when subjected to an electric field due to variations in their electrical charge and molecular size. The process begins with preparing a hemolysate from red blood cells, which is then applied to a supporting medium such as cellulose acetate or agarose gel. When an electric current is applied (typically at pH 8.4-8.6), hemoglobin molecules separate into distinct bands based on their net charge. Hemoglobin A (normal adult hemoglobin) migrates toward the cathode, while abnormal variants like hemoglobin S (sickle hemoglobin) and hemoglobin C migrate at different positions. After separation, the gel is stained with specific dyes like Ponceau S or amido black to visualize the hemoglobin bands. Densitometry scanning then quantifies the percentage of each hemoglobin variant present. Modern systems often use capillary electrophoresis or high-performance liquid chromatography as complementary methods for improved resolution and quantification.

Why It Matters

Hemoglobin electrophoresis has profound clinical significance as it enables early diagnosis and management of hemoglobin disorders that affect millions worldwide. For sickle cell disease, early detection through newborn screening programs (implemented nationwide in the U.S. by 2006) allows for prompt initiation of penicillin prophylaxis, which reduces mortality from pneumococcal sepsis by approximately 84% in affected infants. The test guides treatment decisions, such as determining eligibility for hydroxyurea therapy or bone marrow transplantation. In prenatal diagnosis, hemoglobin electrophoresis of fetal blood samples obtained via chorionic villus sampling or amniocentesis can identify serious hemoglobinopathies as early as 10-12 weeks gestation. The technique also plays a crucial role in population screening programs in regions with high prevalence of hemoglobin disorders, including parts of Africa, the Mediterranean, and Southeast Asia. Beyond clinical applications, hemoglobin electrophoresis contributes to genetic counseling and epidemiological studies tracking the distribution and frequency of hemoglobin variants across different populations.